To facilitate the analysis of targeted drugs under high sample volume testing environment, an extraction, derivatization and gas chromatographic-mass spectrometric analysis method was developed for simultaneously determination of amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyethylamphetamine (MDEA), ketamine, and norketamine in urine. This method utilized solid-phase extraction in conjunction with derivatization using heptafluorobutyric anhydride (HFBA) as the derivatization reagent. Using a 1-mL sample, the limits of quantitation achieved for the analysis of AMP, MAMP, MDA, MDMA, MDEA, ketamine, and norketamine were 25, 15, 60, 60, 70, 25, and 30 ng/mL, respectively. Upper limits of quantitation were 8000 ng/mL for all amphetamines and 6000 ng/mL for ketamine and norketamine. Except for dehydronorketamine (DHNK), within-day and between-day precisions (as expressed in CV%) for quality control samples were ≤ 3.1% and ≤ 4.95%, respectively. Except DHNK, the within-day accuracy ranged between 96.0% and 110.7% and the between-day accuracy ranged between 96.9% and 108.7%. A group of 107 urine samples previously determined to contain the target analytes were analyzed by this new approach. Quantitative data produced by both methods agreed well. With this new approach, we were able to use a single analytical protocol to conduct the confirmation test for samples that preliminarily tested positive (by immunoassay) for amphetamines, ketamine, or both.
Introduction
Ketamine (K), is catalogued as a synthetic anesthetic for human and veterinary surgery (1) . It induces sedation, immobility, and amnesia. K is cheap and easily shared because of the small size of the pills. It is prepared in powder or liquid forms that are taken orally, often in combination with alcohol or other chemical drugs to increase their effect.
Club drugs are often used at nightclubs, rave parties, and music festivals to increase sensory stimulation and social intimacy; they are especially popular among the young for recreational purposes (2) . Amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) usage have increased in Taiwan and have garnered increasing media attention. Since 2002, ecstasy has become the most frequently abused illicit drug among adolescents in Taiwan (3) . Concomitant use of other harmful substances with ecstasy is also very common (4) .
With the popularity of disco-dancing club culture, K has been increasingly abused (5, 6) . In the U.S., MDMA mixed with K appeared in 39% of all K-related emergency visits. Lua et al. (6) reported that more than 43% of abusers in rave parties in Taiwan used K and MDMA together. Thus, simultaneous detection and determination of amphetamines and ketamines is advantageous in monitoring multiple drugs of abuse.
Norketamine (NK) and dehydronorketamine (DHNK) are the major metabolites of K (7). There have been several methods published for the determination of AMP, MA, MDA, MDMA, and MDEA (2, (8) (9) (10) (11) and K and NK using mass spectrometry (MS) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Gas chromatography (GC)-MS is still the gold standard analytical technique for drugs of abuse because of its ability to provide unambiguous identification of compounds and its good sensitivity. Because of the relatively high polarity of am-phetamines, chemical derivatization is necessary in order to increase volatility and to form more characteristic mass spectral fragment ions.
Lin et al. (8) reported simultaneous determination of amphetamines, MDMA, and ketamines in urine by GC-MS with liquid-liquid extraction, which is more time consuming and less amenable to automation than solid-phase extraction. Stout et al. (11) reported simultaneous determination of amphetamine and MDMA in urine by SPE; K and NK were not included in the study. The aim of the current study was to simultaneously determine amphetamine, methamphetamine, MDMA, MDA, MDEA, K, NK, and DHNK levels in urine using GC-MS with SPE. The standards and internal standard were diluted or dissolved to 10,000 ng/mL as stock solutions. The solutions were then diluted to make the calibration standards and internal standards used in this study. These standards were refrigerated at 4°C during the period of study. Heptafluorobytyric anhydride (HFBA) derivatization reagents were purchased from Macherey-Nagel (Bethlehem, PA).
Materials and Methods

Chemicals and reagents
The Drugs of Abuse SPE column (DAU) (specification: 1.30-1.70 mg per disc) was purchased from Varian (Palo Alto, CA). Potassium phosphate monobasic (KH 2 PO 4 ), ammonium (NH 3 ), 25% hydrochloric acid (HCl), 12.1 M glacial acetic acid (CH 3 COOH), 17.4 M, sodium hydroxide (NaOH), dichloromethane, and 2-propanol were reagent grade.
Apparatus
Urine extraction was performed with automatic SPE equipment, a Rapid Trace SPE workstation from Zymark (Hopkinton, MA), and evaporation of the extracted solution by nitrogen purging was carried out in a Turbo Vap LV Evaporator (Zymark).
The GC-MS method was performed using an Agilent 6890N series GC (Hewlett-Packard, Palo Alto, CA) connected with an Agilent 5973N series mass selective detector (Hewlett-Packard). The instrument was operated in full-scan mode and in selected ion monitoring mode (SIM) to determine the qualifier and quantifier ions. The GC column used was an Agilent HP-1 MS capillary column (12 m × 0.2-mm i.d., 0.33-µm film thickness, J&W Scientific, Folsom, CA). The GC was operated in splitless mode during sample injection by an Agilent 7683 autosampler.
The injection port was maintained at 260°C, and GC oven conditions started at 80°C for 1.0 min with a ramp of 25-40°C/min to 288°C for 1.45 min. Total run time was 10 min. Helium was used as the carrier gas at a flow rate of 1 mL/min.
Sample preparation
To 1 mL of urine in a 13-× 100-mm tube, 50 µL of internal standard (10 µg/mL AMP-d 11 
SPE
The samples were poured into 3-mL DAU columns. The target compounds were eluted into automated Rapid Trace SPE Workstation Zymark vials with the addition of 1.0 mL dichloromethane/2-propanol/ammonium (NH 3 to the column. Samples were then evaporated to dryness under a stream of nitrogen.
Derivatization
The extracted samples were dissolved with 0.050 mL ethyl acetate, and then was derivatized using 0.050 mL HFBA. Samples were capped, mixed, and incubated for 30 min at 65-70°C. Samples were removed from the heat block, allowed to cool at room temperature, and then were evaporated to dryness. Samples were then reconstituted with 0.05 mL of ethyl acetate for GC-MS analysis, and 1 µL was injected.
Reference methods
Detailed procedures for amphetamine and ketamine have been described in previous publications (11, 21) . Briefly, the analytical procedure for amphetamine was as follows: in 2 mL of urine, the samples were extracted with water and 0.1 M HCl. The target compounds were eluted into automated liquid sampler vials with the addition of ethyl acetate/methanol/ammonium hydroxide. After evaporation, samples were derivatized with HFBA in ethyl acetate. Samples were capped, mixed, and incubated for 10 min at 60-70°C. Samples were then reconstituted with 0.100 mL of ethyl acetate for GC-MS analysis.
The analytical procedure for ketamine was as follows: 1 mL drug-free urine was spiked with IS and then alkalized with 1 mL carbonate/bicarbonate buffer. Extraction was performed on a Zymark system. The cartridge was conditioned with 2 mL methanol, followed by water and buffer. After loading the sample, the cartridge was washed with 2 mL rinse solution. Analytes retained were then eluted with methanol. The methanol eluate was evaporated, and reconstituted with ethyl acetate. GC oven temperature was programmed to rise initially from 130 to 170°C at 10°C/min. A 2-µL aliquot was injected in splitless mode.
Results and Discussion
The total chromatogram of HFBA derivatives of the amphetamines, ketamines, and two structurally related sympathomimetic amines (ephedrine, pseudoephedrine) is shown in Figure 1 . All compounds were well separated chromatographically. The retention times of the derivatized drugs and their deuterated analogues are shown in Table I . The mass spectra of HFBA derivatives of K, NK, DHNK, amphetamine, MDA, MDMA, and MDEA are presented in Figure 2 . The mass spectra of derivatized ephedrine and pseudoephedrine are nearly identical because they are stereoisomers, but as shown in Figure 3 , our data revealed that although the abundance ratios of 210/254 were similar for methamphetamine, ephedrine, and pseudoephedrine, the 118/254 ratios were quite small (< 1%) for ephedrine and pseudoephedrine in mass spectra of methamphetamine, ephedrine, and pseudoephedrine.
In the studies by Lin and Lua (8), they used TFAA for derivatization. Their assay precision using HFBA derivative was 32.9%, whereas the assay precision using HFBA derivative was only 4.95% in our study. We compared four different temperatures (60°C, 70°C, 80°C, and 100°C) with derivatization by HFBA and found that if the derivatization temperature using HFBA was set at 80°C, then there were thermal rearrangements of amphetamines. Almost no amphetamines peaks were seen with derivative temperature set at 100°C (as shown in Figure 4 ). In our studies, we used 65-70°C for derivatization, and Lin and Lua (8) used 90°C for derivatization in their studies. The other two factors in the poor precision using HFBA in Lin and Lua's studies were possibly 1. selecting the HP-5 column instead of our HP-1 column, which had less polarity, and 2. selecting an unstable ion that had crosscontribution data in SIM mode, as in another study (21) .
Precision and accuracy
Interassay, intraassay, and accuracy data for AMP/MAMP/ MDA/MDMA/K/NK were determined with low, medium, and high concentration QC samples. Intraassay data (n = 5) and in- terassay precision (n = 5) were expressed as percent relative standard deviation (% RSD), and accuracy was expressed as the degree of closeness of measurements of a quantity to its actual (true) value. The results of precision and accuracy are shown in Table II . Except for DHNK, the within-day precision for the QCs was always less than 3.1%, and the between-day precision was less than 4.95%. Except for DHNK, the within-day accuracy ranged between 96.0% and 110.7%, and the between-day accuracy ranged between 96.9% and 108.7%.
Recovery
Method recovery was assessed by analyzing two groups of three levels of drug-free urine. Samples were fortified with AMP/MAMP MDA/MDMA at 500 ng/mL and K/NK at 100 ng/mL. Extraction recovery of the analytes was determined by comparing the response ratios (analyte/internal standard) between two sets of control samples. The internal standard was spiked into every sample before SPE. For the recovery study, one set of samples was fortified with all analytes at specific concentrations before extraction, and another set was fortified with the analytes after extraction. Recovery was calculated by dividing the response ratios of the two sets (22) . In this study, as shown in Table II , not including DHNK, recovery rates were 94.8%, 94.1%, 97.1%, 96.2%, 91.5%, and 89.8% for AMP, MAMP, MDA, MDMA, K, and NK, respectively.
Limits of linearity (LOL), detection (LOD), and quantitation (LOQ)
The linearity of the method was investigated by calculating the regression line by the method of least squares and expressed by the correlation coefficient (r 2 ). The linearity of 6 compounds was determined with at least 10 concentrations, not including the blank matrix. The concentrations of each calibrator were within ±20% of the target concentration when calculated against the full 10-point calibration curve.
The sensitivity of the method was evaluated by determining the LOD and LOQ. The LOD was defined as the concentration at which all routine GC-MS acceptance criteria (retention time within 2% of the amphetamines 500 ng/mL, K 100 ng/mL calibrator, or ion ratios within ±20% of the amphetamines 500 ng/mL, K 100 ng/mL calibrator) are met at least 90% of the time (23, 24) . The LOQ was defined as the concentration at which all acceptance criteria are met and the quantitative value is within ± 20% of the target concentration. The LOL was defined as the highest concentration that quantitated within 20% of the expected value and with two ion abundance ratios for the analyte within 20% of those of the calibrators. The results of LOD, LOQ, and LOL are presented in Table III . The LOQ values for the amphetamine and methamphetamine in this study were 25 and 15 ng/mL, respectively. The LOD and LOQ values for the ketamine were 10 and 25 ng/mL, respectively.
Comparative study
A group of 107 human urine specimens, which were obtained from police trustees in Taiwan, was used for this study. These samples contained different target analytes. Regression analysis of results obtained with the new method compared to those obtained using previous methods is shown in Figure 5 . The results of this regression analysis revealed that there was excellent correlation between our current method and the previous reference method. For NK, the slope was 0.886, probably because we used HFBA for derivatization, whereas Cheng et al. (21) did not use any derivative. With derivatization, the mass sensitivity will be better, and the peak will be sharper. The precision, accuracy, and recovery rate for NK in this study were better than those of Cheng et al. (21) . MDEA has rarely been detected in Taiwan, and we did not have any MDEA cases, so there were no comparative data for MDEA in this study. Among 19 urine specimens that contained all 3 K analytes simultaneously, the DHNK concentration was the highest in 14 cases, and NK was the highest in 4 cases. Although DHNK usually had the highest concentrations among the K metabolites, its unstable precision, accuracy, and recovery rate in this study indicate that DHNK may not be the appropriate target analyte for K abuse.
Conclusions
The interference potential from structurally related sympathomimetic amines, including ephedrine and pseudoephedrine, was eliminated by monitored ion choice and chromatographic separation. Our study suggests that this method is a rapid and sensitive method for the simultaneous quantitation of AMP, MAMP, MDA, MDEA, MDMA, K, and NK concentrations in urine using HFBA derivatives with GC-MS by SPE.
